Compara a los mejores médicos de Quimioterapia para el cáncer de mama y precios en Turquía. Encuentra aquí tu mejor opción.

Elige el país con los mejores precios para servicios médicos

Compara precios de Quimioterapia para el cáncer de mama entre los principales países

Toca un país para ver los mejores médicos y precios

Ukraine

Turkey

Mexico

Thailand

Czech Republic

Poland

$1,200 - $2,500

$1,200 - $3,500

$2,000 - $5,000

$3,000 - $7,000

$3,000 - $6,000

$3,500 - $6,500

$2,000

$4,000

$6,000

Lo que realmente pagan los pacientes de Bookimed por Quimioterapia para el cáncer de mama en Turquía

Intervalo más popular

$800

$1.2K

$1.6K

$2K

$2.4K

$2.8K

$3.2K

$3.6K

$1,400 – $2,300

La mayoría de los pacientes paga dentro de este rango

El costo exacto depende del médico elegido, la técnica, las áreas tratadas y tus necesidades individuales.

Obtén un presupuesto exacto para tu caso.

Recibe planes de tratamiento personalizados gratuitos y elige la mejor opción. Sin compromiso · Sin pagos por nuestros servicios

Muhammed Gomec

17 años de experiencia
Ubicación: Turquía, Sivas
Clínica:
5.0
Medicana Sivas Hospital

Cita con el médico

Precio a consultar

Alandag Celal

17 años de experiencia
Ubicación: Turquía, Sivas
Clínica:
5.0
Medicana Sivas Hospital

Cita con el médico

Precio a consultar

Bookimed Insights: Principales especialistas en Quimioterapia para el cáncer de mama en Turquía (2026)

Bookimed ha coordinado 3 solicitudes para Quimioterapia para el cáncer de mama en Turquía, colaborando con 2 especialistas de primer nivel. Los médicos en esta tabla se seleccionan por sus credenciales internacionales, experiencia clínica y resultados de pacientes. La clasificación de 2026 se elabora con datos verificados de casos reales y programas actuales de nuestras clínicas asociadas.

Clasificación	Médico	experiencia	Buena opción para	Qué los distingue	Ubicación de la clínica	Consulta

FAQ

Estas preguntas frecuentes provienen de pacientes reales que buscan atención médica a través de Bookimed. Las respuestas son proporcionadas por coordinadores médicos experimentados y representantes autorizados de las clínicas.

Who are some of the top-rated medical oncologists and breast cancer doctors in Turkey?

Turkey hosts top-rated medical oncologists who specialize in personalized breast cancer care at JCI-accredited centers. These specialists often hold European Society for Medical Oncology (ESMO) certification and international fellowships. They provide advanced systemic therapies like targeted treatment and immunotherapy alongside traditional chemotherapy protocols.

Dr. Yesim Yildirim: An ESMO-certified professor at Anadolu Medical Center with over 20 years of experience.
Dr. Bulent Karagoz: Specializes in tumor immunotherapy and biology at Anadolu Medical Center in Istanbul.
Dr. Mustafa Solak: Trained at MD Anderson Cancer Center, practicing at Hisar Hospital Intercontinental.
Dr. Seref Komurcu: An ECFMG-certified professor at Anadolu Medical Center with 110+ research publications.

Bookimed Expert Insight: Data shows that leading Turkish oncologists like Prof. Necdet Uskent and Prof. Cemil Bilir have over 20 to 40 years of experience. Many have rotated through elite US institutions such as the Cleveland Clinic or MD Anderson. This international exposure allows them to implement the latest global oncology protocols for complex breast cancer cases.

Patient Consensus: Patients note that coordinated care between medical oncologists and surgeons at centers like Anadolu makes a big difference. They emphasize how important it is to have clear, written chemo schedules. Many felt more confident when doctors proactive managed side effects rather than just following a rigid plan.

What credentials and certifications do leading Turkish breast cancer oncologists hold?

Leading Turkish breast cancer oncologists hold advanced academic titles like Professor and Associate Professor. They possess mandatory Ministry of Health licenses and specialized medical oncology certifications. Many experts hold international credentials from the European Society for Medical Oncology and have completed fellowships at renowned cancer centers.

Academic ranking: Specialists often reach the title of Professor, indicating decades of clinical leadership.
Subspecialty training: Doctors complete dedicated 3-year fellowships specifically in medical oncology or internal medicine.
International certification: Many experts hold ESMO Board Certification or ECFMG validation for United States standards.
Global fellowships: Leading oncologists trained at top institutes like MD Anderson or Memorial Sloan Kettering.

Bookimed Expert Insight: A prevailing trend among top Turkish oncologists is the combination of military medical training with international research. Dr. Bulent Karagoz and Dr. Seref Komurcu at Anadolu Medical Center both held leadership roles at the Gulhane Military Medical Academy. This background often correlates with a high volume of complex cases and a strong focus on tumor biology research.

Patient Consensus: Patients often mention feeling reassured by the academic titles of their doctors. Many were surprised by how many specialists have over 20 years of experience and international training. They note that doctors like Dr. Yesim Yildirim explain complex immunotherapy options in very simple terms.

Do breast cancer doctors in Turkey follow international chemotherapy protocols?

Breast cancer doctors in Turkey strictly follow international chemotherapy protocols to provide standardized care. Leading clinics align their treatments with guidelines from ASCO, ESMO, and the NCCN. Specialists utilize modern HER2 testing and genetic analysis to tailor drug regimens for every patient.

Global certifications: Hospitals like Anadolu Medical Center hold OECI and ESMO clinical center accreditations.
Expert training: Dr. Yesim Yildirim completed advanced oncology training at Mount Vernon Cancer Center.
Specialized fellowships: Dr. Mustafa Solak gained experience at the University of Texas MD Anderson Center.
Clinical research: Dr. Bulent Karagoz has authored over 40 cancer research publications helping advance care.

Bookimed Expert Insight: Turkey serves as a hub for oncology expertise where doctors often hold memberships in both Turkish and European medical societies. Dr. Eda Tanrikulu ranked third nationally in specialty exams and participates in international clinical studies. This dual engagement ensures patients receive the latest systemic therapies currently used in Western Europe and the US.

Patient Consensus: Patients note that treatment feels very consistent with standards they recognize from home. They emphasize that care teams focus entirely on the results and often include professional translators. Many survivors felt reassured by the coordinated approach between oncomammologists, anesthesiologists, and plastic surgeons.

How do Turkish oncologists determine a patient's customized chemotherapy plan?

Turkish oncologists design customized chemotherapy plans by integrating international ESMO and NCCN guidelines with tumor biology. Specialists utilize molecular profiling and multidisciplinary tumor boards to select specific drug combinations. These protocols account for genetic markers, organ function, and patient performance status.

Molecular profiling: Specialists analyze HER2, ER/PR receptors, and Ki-67 to target tumor vulnerabilities.
Genomic testing: Doctors use Oncotype assays to determine if chemotherapy is necessary for borderline cases.
Multidisciplinary boards: Teams of pathologists, radiologists, and surgeons review cases to align treatment steps.
Physiological metrics: Dosages are calculated using body surface area and precise liver clearance metrics.

Bookimed Expert Insight: Coordination between internal research and clinical practice is common among top Turkish specialists. For example, Dr. Yesim Yildirim at Anadolu Medical Center has 80+ publications and uses international training from the UK and Israel to apply advanced immunotherapy alongside chemotherapy. This academic background allows doctors to adjust protocols in real-time if a tumor develops resistance.

Patient Consensus: Patients note that their treatment plans often change after the surgical team provides the final pathology report. Many felt relieved when doctors explained that markers like lymph-node status or genomic risk, rather than just stage, drove their specific drug choice. They also appreciate how teams coordinate 24/7 to manage side effects during active cycles.

Los mejores médicos de Quimioterapia para el cáncer de mama en Sivas - TOP-2 médicos

Recibe cotizaciones de 3 de los mejores especialistas en Quimioterapia para el cáncer de mama en Turquía